An assay using an antiserum raised against a dexamethasone 21-hemisuccinate conjugate and the heterologous radioligand dexamethasone 21-(carboxymethyl) ether was developed, validated, and used to study the pharmacokinetics of this steroid for 12 h following administration to patients with congenital adrenal hyperplasia. Coupling the antiserum to magnetizable cellulose allowed rapid separation of bound/free steroid. A C-21 rather than a C-3 antiserum was used to minimize interference with a main metabolite, 6β-hydroxydexamethasone. Close correspondence of assay (0·35 nmol/L) and curve (0·25 nmol/L) sensitivities suggests that interference by matrix effects is minimal. This was confirmed by good agreement in data from the in-house assay and that of a reference procedure. Good precision was demonstrated by the precision profile and Shewhart chart quality control data. The latter also demonstrated the assay was robust and reliable in routine practice.
HughesIAReadGF. Menarche and subsequent ovarian function in girls with congenital adrenal hyperplasia. Hormone Res1986; 16: 100–6.
2.
AranaGWWorkmanRJBaldessariniRJ. Association between low plasma levels of dexamethasone and elevated levels of cortisol in psychiatric patients given dexamethasone. Am J Psychiatry1984; 141: 1619–20.
3.
HolsboerFHaackDGerkenAVecseiP.Plasma dexamethasone concentrations and differential suppression response of cortisol and corticosterone in depressives and controls. Biol Psychiatry1984; 19: 281–91.
4.
WorkmanRJVaughnWKStoneWJ. Dexamethasone suppression testing in chronic renal failure: Pharmacokinetics of dexamethasone and demonstration of a normal hypothalamic-pituitary-adrenal axis. J Clin Endocrinol Metab1986; 63: 741–6.
GillilandJMMorrisHA. A radioimmunoassay for urinary and serum dexamethasone. Commun Lab Med1986; 2: 6–8.
9.
CarsonSWHalbreichUYehCMAsnisGGoldsteinS.Cortisol suppression per nanogram per millilitre of plasma dexamethasone in depressive and normal subjects. Biol Psychiatry1988; 24: 569–77.
10.
ErlangerBFBorekKFBeiserSMLiebermanS.Steroid protein conjugates. Preparation and characteristics of conjugates of bovine serum albumin with testosterone and with cortisone. J Biol Chem1957; 228: 713–27.
11.
RaoPNMoorePHPetersonDMTcholakianRK. Synthesis of new steroid haptens for radioimmunoassay. Part 5. 19–0–carboxymethyl ether derivative of testosterone. A highly specific antiserum for immunoassay of testosterone from both male and female plasma without chromatography. J Steroid Biochem1978; 9: 539–45.
12.
HillierSGReadGF. Radioimmunoassay for plasma norethisterone and testosterone using antisera raised against C-11 conjugated haptens and radio-iodinated ligand. J Endocrinol1975; 67: 5P–6P.
13.
HunterWMNarsPWRutherfordFJ. Preparation and behaviour of [125I]-labelled radioligands for phenolic and neutral steroids. In: CameronEHDHillierSGGriffithsK eds. Steroid Immunoassays: Proceedings of the Vth Tenovus Workshop. Cardiff: Alpha Omega, 1975; pp 141–52.
14.
SethJBrownLM. A simple radioimmunoassay for plasma cortisol. Clin Chim Acta1978; 86: 109–20.
15.
RodbardDHuttDM. Statistical analysis of radioimmunoassay and immunoradiometric (labelled antibody) assays: A generalised, weighted, iterative, least squares method for logistic curve fitting. In: Radioimmunoassays and Related Procedures in Clinical Medicine and Research. Vienna: IAEA, 1974; 165–92.
Lejeune-LenainCBossonDLinkowskiP.Specific determination of plasma dexamethasone by HPLC and RIA—application to standard dexamethasone suppression test in psychiatric patients. Clin Chim Acta1989; 179: 13–22.
18.
DyasJReadGFTapatiGuha-MaulikHughesIARiad-FahmyD.A rapid assay for 17α-hydroxyprogesterone in plasma, saliva and amniotic fluid using a magnetisable solid-phase antiserum. Ann Clin Biochem1984; 21: 417–24.
19.
KaiserHSpeckerH.Bewertung und Vergleich von Analysenverfahren. Z Anal Chemie1956; 149: 46–66.
20.
BrownJBBulbrookRDGreenwoodFC. An evaluation of a chemical method for the estimation of oestradiol, oestrone and oestradiol 17β in human urine. J Endocrinol1957; 16: 41–8.
21.
KasuyaYAlthausJRFreemanJPMitchumRKSkellyJP. Quantitative determination of dexamethasone in human plasma by stable isotope dilution mass spectrometry. J Pharmaceut Sci1984; 73: 446–51.
22.
MinagawaKKasuyaYBabaSKnappGSkellyJP. Identification and quantification of 6β-hydroxydexamethasone as a major urinary metabolite of dexamethasone in man. Steroids1986; 47: 175–88.
23.
LooJCKJordanN.High performance liquid chromatographic analysis for synthetic corticosteroids in human plasma and urine by electron-impact mass-spectrometry. J Chromatogr1985; 343: 231–7.
24.
TsueiSEAshleyJJMooreRGMcBrideWG. Quantitation of dexamethasone in biological fluids using high performance liquid chromatography. J Chromatogr1973; 145: 213–20.
25.
RoseJQJuskoWJ. Corticosteroid analysis in biological fluids by high performance liquid chromatography. J Chromatogr1979; 162: 273–80.
26.
ChamBSSadowskiBO'MagorWJde WyttCNBochnerFEadieMJ. High performance liquid chromatographic assay of dexamethasone in plasma and tissue. Ther Drug Monit1980; 2: 373–7.
27.
DawsonRKonturPMorjauA.High performance liquid chromatographic (HPLC) separation and quantification of endogenous glucocorticoids after solid-phase extraction from plasma. Hormone Res1984; 20: 89–94.
28.
CarrollBJSchroederKMukhopadhyaySPlasma dexamethasone concentrations and cortisol suppression response in patients with endogenous depression. J Clin Endocrinol Metab1980; 51: 433–7.
29.
HaqueNThrasherKWerkEEKnowlesHCSholitonLJ. Studies on dexamethasone metabolism in man: Effect of diphenylhydantoin. J Clin Endocrinol Metab1972; 34: 44–50.
30.
KawaiSIchikawaYHommaM.Differences in metabolic properties amongst cortisol, prednisolone, and dexamethasone in liver and renal disease: Accelerated metabolism of dexamethasone in renal failures. J Clin Endocrinol Metab1985; 60: 848–54.
31.
HorrocksPMLondonDR. Effects of long term dexamethasone treatment in adult patients with congenital adrenal hyperplasia. Clin Endocrinol1987; 27: 635–42.
